paxilline has been researched along with Acute Necrotizing Pancreatitis in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, H; Fan, KH; Jiang, Y; Jin, WH; Jing, L; Ren, JD; Wang, SH; Wu, J; Wu, XC; Xing, YJ; Yu, BT | 1 |
1 other study(ies) available for paxilline and Acute Necrotizing Pancreatitis
| Article | Year |
|---|---|
Pharmacological blockade of the MaxiK channel attenuates experimental acute pancreatitis and associated lung injury in rats.
Topics: Animals; Chemokine CXCL2; Disease Progression; Humans; Large-Conductance Calcium-Activated Potassium Channels; Liver; Lung; Lung Injury; Macrophages; Male; Mice; Models, Animal; Pancreatitis, Acute Necrotizing; Paxillin; Rats; Rats, Wistar; Taurocholic Acid; Tumor Necrosis Factor-alpha | 2014 |